Biogen (BIIB, $190.52) was a top loser over the last three months, falling -2 to $190.52 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending April 18, 2024, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.